Compounds > losartan

losartan and minocycline

losartan has been researched along with minocycline in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (10.00)	18.2507
2000's	3 (30.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
de Gasparo, M; Pfeilschifter, J; Ramjoué, H; Whitebread, S	1
Bougaki, M; Chang, K; Muroya, M; Uchida, K; Yamada, Y	1
Biancardi, VC; de Kloet, AD; Krause, EG; Stern, JE; Stranahan, AM	1

Reviews

1 review(s) available for losartan and minocycline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

9 other study(ies) available for losartan and minocycline

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Angiotensin II binding sites on micro-organisms contaminating cell cultures. Regulatory peptides, 1993, Mar-19, Volume: 44, Issue:2 Topics: Acholeplasma laidlawii; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cells, Cultured; Diterpenes; Drug Therapy, Combination; Glomerular Mesangium; Imidazoles; Losartan; Minocycline; Muscle, Smooth, Vascular; Rats; Receptors, Angiotensin; Tetrazoles	1993
Analysis of cytotoxicity induced by proinflammatory cytokines in the human alveolar epithelial cell line A549. Bioscience trends, 2012, Volume: 6, Issue:2 Topics: Apoptosis; Benzimidazoles; Benzoates; Catalase; Cell Line; Cytokines; Dexamethasone; Dimethyl Sulfoxide; Doxycycline; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Humans; Interferon-gamma; Interleukin-1beta; Losartan; Minocycline; Pulmonary Alveoli; Telmisartan; Tumor Necrosis Factor-alpha	2012
Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus. American journal of physiology. Heart and circulatory physiology, 2016, Feb-01, Volume: 310, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Bacterial Agents; Immunity, Innate; Inflammation; Losartan; Male; Mice; Mice, Inbred C3H; Mice, Knockout; Microglia; Minocycline; Oxidative Stress; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Toll-Like Receptor 4	2016